<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kappel D</submitter><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><pagination>26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11442302</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(1)</volume><pubmed_abstract>&lt;i>Candida auris&lt;/i> is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to elucidate the temporal and geographic epidemiology of drug-resistant &lt;i>C. auris&lt;/i> within the UK. We analysed a representative sample of over 200 isolates from multiple UK hospitals to assess the number and timings of &lt;i>C. auris&lt;/i> introductions and infer subsequent patterns of inter- and intra-hospital transmission of azole drug-resistant isolates. We identify at least one introduction from Clade I and two from Clade III into the UK, and observe temporal and geographical evidence for multiple transmission events of antifungal drug resistant isolates between hospitals and identified local within-hospital patient-to-patient transmission event</pubmed_abstract><journal>npj antimicrobials and resistance</journal><pubmed_title>Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant &amp;lt;i&amp;gt;Candida auris&amp;lt;/i&amp;gt;.</pubmed_title><pmcid>PMC11442302</pmcid><funding_grant_id>219551/Z/19/Z</funding_grant_id><funding_grant_id>MR/R015600/1</funding_grant_id><pubmed_authors>Rhodes J</pubmed_authors><pubmed_authors>Borman A</pubmed_authors><pubmed_authors>Brown CS</pubmed_authors><pubmed_authors>Fisher MC</pubmed_authors><pubmed_authors>Schlenz S</pubmed_authors><pubmed_authors>Kappel D</pubmed_authors><pubmed_authors>Abdolrasouli A</pubmed_authors><pubmed_authors>Eyre DW</pubmed_authors><pubmed_authors>Jeffery K</pubmed_authors><pubmed_authors>Brackin A</pubmed_authors><pubmed_authors>Aanensen DM</pubmed_authors><pubmed_authors>Holmes A</pubmed_authors><pubmed_authors>Gifford H</pubmed_authors><pubmed_authors>Armstrong-James D</pubmed_authors><pubmed_authors>Johnson E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant &amp;lt;i&amp;gt;Candida auris&amp;lt;/i&amp;gt;.</name><description>&lt;i>Candida auris&lt;/i> is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to elucidate the temporal and geographic epidemiology of drug-resistant &lt;i>C. auris&lt;/i> within the UK. We analysed a representative sample of over 200 isolates from multiple UK hospitals to assess the number and timings of &lt;i>C. auris&lt;/i> introductions and infer subsequent patterns of inter- and intra-hospital transmission of azole drug-resistant isolates. We identify at least one introduction from Clade I and two from Clade III into the UK, and observe temporal and geographical evidence for multiple transmission events of antifungal drug resistant isolates between hospitals and identified local within-hospital patient-to-patient transmission event</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-07-15T04:09:25.336Z</modification><creation>2025-04-04T01:54:47.146Z</creation></dates><accession>S-EPMC11442302</accession><cross_references><pubmed>39359891</pubmed><doi>10.1038/s44259-024-00043-6</doi></cross_references></HashMap>